R", which contains recombinant interleukin 1 beta, is introduced. Time of exposition is 48 hours, then turunda is extracted, and fragments are fixed by gypsum bandage. Efficiency of carried out therapy is evaluated on the basis of analysis of levels of pro-inflammatory and pro-allergic interleukins in nasal washes before reposition of nose bones and after 7 days after its carrying out. Effect is considered positive in case of 2-4 times reduction of interleukin-4 and/or receptor antagonist of interleukin-1.;EFFECT: invention makes it possible to carry out preventive treatment of complications after nose trauma.;4 dwg, 2 tbl, 1 ex"/>
公开/公告号RU2559587C2
专利类型
公开/公告日2015-08-10
原文格式PDF
申请/专利权人 TJUMENEV ALEKSANDR VIKTOROVICH;SHABALDINA ELENA VIKTOROVNA;SHABALDIN ANDREJ VLADIMIROVICH;PAVLOV VENIAMIN VITALEVICH;
申请/专利号RU20130146329
发明设计人 TJUMENEV ALEKSANDR VIKTOROVICH;SHABALDINA ELENA VIKTOROVNA;PAVLOV VENIAMIN VITALEVICH;SHABALDIN ANDREJ VLADIMIROVICH;
申请日2013-10-16
分类号A61K38/20;A61M31/00;G01N33/53;
国家 RU
入库时间 2022-08-21 14:56:13